MML Investors Services’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.23M | Buy |
9,008
+1,935
| +27% | +$592K | 0.01% | 1241 |
|
|
2026
Q1 | $1.77M | Sell |
7,073
-5,265
| -43% | -$1.31M | ﹤0.01% | 1388 |
|
|
2025
Q4 | $3.39M | Sell |
12,338
-1,264
| -9% | -$346K | 0.01% | 1080 |
|
|
2025
Q3 | $3.57M | Sell |
13,602
-5,104
| -27% | -$1.24M | 0.01% | 1004 |
|
|
2025
Q2 | $4.09M | Sell |
18,706
-2,355
| -11% | -$503K | 0.01% | 885 |
|
|
2025
Q1 | $4.71M | Buy |
21,061
+819
| +4% | +$226K | 0.02% | 750 |
|
|
2024
Q4 | $6.63M | Buy |
20,242
+1,725
| +9% | +$543K | 0.02% | 596 |
|
|
2024
Q3 | $5.56M | Buy |
18,517
+437
| +2% | +$134K | 0.02% | 644 |
|
|
2024
Q2 | $5.96M | Buy |
18,080
+3,135
| +21% | +$1.11M | 0.02% | 587 |
|
|
2024
Q1 | $5.91M | Sell |
14,945
-1,407
| -9% | -$520K | 0.02% | 571 |
|
|
2023
Q4 | $5.76M | Buy |
16,352
+3,157
| +24% | +$1.12M | 0.03% | 542 |
|
|
2023
Q3 | $4.95M | Buy |
13,195
+662
| +5% | +$256K | 0.03% | 541 |
|
|
2023
Q2 | $4.79M | Buy |
12,533
+678
| +6% | +$242K | 0.03% | 552 |
|
|
2023
Q1 | $4.11M | Sell |
11,855
-482
| -4% | -$141K | 0.03% | 526 |
|
|
2022
Q4 | $2.9M | Sell |
12,337
-5,875
| -32% | -$1.39M | 0.02% | 677 |
|
|
2022
Q3 | $4.48M | Sell |
18,212
-1,486
| -8% | -$453K | 0.03% | 475 |
|
|
2022
Q2 | $5.96M | Sell |
19,698
-2,854
| -13% | -$929K | 0.05% | 372 |
|
|
2022
Q1 | $9.26M | Buy |
22,552
+2,429
| +12% | +$951K | 0.07% | 294 |
|
|
2021
Q4 | $9.44M | Buy |
20,123
+1,826
| +10% | +$786K | 0.07% | 286 |
|
|
2021
Q3 | $7.77M | Buy |
18,297
+260
| +1% | +$110K | 0.06% | 310 |
|
|
2021
Q2 | $6.48M | Buy |
18,037
+2,229
| +14% | +$736K | 0.05% | 336 |
|
|
2021
Q1 | $4.45M | Buy |
15,808
+3,286
| +26% | +$940K | 0.04% | 395 |
|
|
2020
Q4 | $3.55M | Buy |
12,522
+1,291
| +11% | +$362K | 0.04% | 402 |
|
|
2020
Q3 | $3.09M | Buy |
11,231
+334
| +3% | +$88.4K | 0.04% | 382 |
|
|
2020
Q2 | $2.48M | Buy |
10,897
+3,592
| +49% | +$706K | 0.03% | 429 |
|
|
2020
Q1 | $1.11M | Buy |
7,305
+1,551
| +27% | +$239K | 0.02% | 591 |
|
|
2019
Q4 | $865K | Buy |
5,754
+566
| +11% | +$82.4K | 0.01% | 766 |
|
|
2019
Q3 | $736K | Buy |
5,188
+324
| +7% | +$44.6K | 0.01% | 804 |
|
|
2019
Q2 | $609K | Buy |
4,864
+1,141
| +31% | +$135K | 0.01% | 926 |
|
|
2019
Q1 | $410K | Buy |
3,723
+17
| +0.5% | +$1.77K | 0.01% | 1108 |
|
|
2018
Q4 | $363K | Buy |
3,706
+694
| +23% | +$75.3K | 0.01% | 1074 |
|
|
2018
Q3 | $372K | Buy |
+3,012
| New | +$338K | 0.01% | 1168 |
|
Other funds holding WST
GIM
MML Investors Services's WST Position: Q2 2026 in Review
MML Investors Services increased its West Pharmaceutical (WST) stake by 27% in Q2 2026, buying an estimated $592K and bringing the position to 9,008 shares worth $3.23M. The position accounts for 0.01% of the portfolio, ranked #1241.
MML Investors Services first reported a position in WST in Q3 2018 and has held it in 32 quarters since. The position peaked at $9.44M in Q4 2021. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.
- MML Investors Services held 9,008 shares of West Pharmaceutical worth $3.23M as of Q2 2026.
- MML Investors Services bought 1,935 West Pharmaceutical shares in Q2 2026, an estimated $592K.
- West Pharmaceutical made up 0.01% of MML Investors Services's portfolio in Q2 2026, its #1241 holding.
- MML Investors Services first reported a position in West Pharmaceutical in Q3 2018 and has held it in 32 quarters since.
- MML Investors Services's West Pharmaceutical position peaked at $9.44M in Q4 2021.
- 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.
Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.